March 21, 2014. As members of the Patient, Consumer, and Public Health Coalition, we strongly support H.R. 1150, the Preservation of Antibiotics for Medical Treatment Act.
Read More »On Health Policy
Letter Regarding Coalition Concerns about H.R. 3742, the Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013
February 20, 2014. As members of the Patient, Consumer, and Public Health Coalition, which includes groups representing physicians, scientists, consumers, and patients, we are writing to express our concerns about H.R. 3742, the Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013.
Read More »Letter of Opposition for the Preventing Regulatory Overreach To Enhance Care Technology (PROTECT) Act of 2014
February 14, 2014. As members of the Patient, Consumer, and Public Health Coalition, we strongly oppose the Preventing Regulatory Overrreach To Enhance Care Technology (PROTECT) Act of 2014.
Read More »NCHR Comments on FDA’s Proposed Rule Regarding Labeling Changes for Approved Drugs and Biological Products
February 10, 2014. As members of the Patient, Consumer, and Public Health Coalition, we are pleased to have the opportunity to strongly support the Food and Drug Administration’s (FDA) proposed rule entitled, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products (78 Fed. Reg. 67985).
Read More »Letter to Congresswoman Rosa DeLauro in Support of Strengthening FDA Safeguards
February 6, 2014. We are writing to thank Representative Rosa DeLauro for her dedication to patients and consumers and work to strengthen safeguards for all medical products sold in the United States.
Read More »